Clinical Trials Logo

Clinical Trial Summary

The primary aim of the work is to compare the efficacy of Sugammadex and neostigmine in reversing rocuronium-induced muscle relaxation to reach complete recovery of neuromuscular block (TOF ratio≥ 0.9) in preterm neonates.

The secondary aim is to evaluate the safety of using Sugammadex in preterm neonates and to detect any complications that may occur in this age group.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04566796
Study type Interventional
Source Alexandria University
Contact Yasser M osman
Phone +201006357996
Email yasseralx@hotmail.com
Status Recruiting
Phase N/A
Start date August 11, 2020
Completion date February 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04997759 - Comparative Efficacy and Safety of Sugammadex and Neostigmine N/A
Recruiting NCT05794503 - Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex Early Phase 1
Not yet recruiting NCT05751603 - Effectiveness on Smooth Extubation According to the Administration Time of Sugammadex N/A
Completed NCT05066035 - Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine Phase 4
Active, not recruiting NCT06081738 - Neostigmine Versus Sugammadex on Renal Functions Phase 4
Completed NCT04471376 - The Effect of Sugammadex During Transcranial Electrical Motor Evoked Potential Monitoring in Spinal Surgery N/A
Recruiting NCT05028088 - Diaphragm Ultrasound to Evaluate the Antagonistic Effect of Sugammadex Phase 4
Recruiting NCT05886218 - Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery
Completed NCT04332627 - Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. Neostigmine Phase 4
Completed NCT04608682 - Effect of Muscle Relaxation Reversal on the Success Rate of Motor Evoked Potential Recording N/A